Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups

Reuters

09/08

Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups

Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including Shanghai Industrial Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR Therapeutics and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2565508501"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2565508501\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2565508501?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-08 14:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2565508501","market":"fut","top_or_hot":-1,"title":"Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including <a href=\"https://laohu8.com/S/SGHIF\">Shanghai Industrial</a> Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-09-08 14:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including <a href=\"https://laohu8.com/S/SGHIF\">Shanghai Industrial</a> Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1607","symbol_name":"新IT概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDLcg1Qdl:1","article_id":"2565508501","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2565508501","pubTimestamp":1757311671,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including Shanghai Industrial Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR Therapeutics and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1607":"新IT概念","BK1193":"电脑硬件、储存设备及电脑周边","03396":"联想控股"},"translate_title":"拜耳公司在中国推出拜耳Co.Lab AdVenture，欢迎新的生物技术初创公司，扩大全球创新网络","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03396":0.9},"content_text":"Bayer AG Expands Global Innovation Network with Launch of Bayer Co.Lab AdVenture in China, Welcoming New Biotech Startups\n    \n\n        Bayer AG has announced the launch of Bayer Co.Lab AdVenture, a new platform designed to accelerate biotech innovation by connecting emerging startups with global venture capital networks. Introduced during the first anniversary of Bayer Co.Lab Shanghai, the platform aims to facilitate access to global financing, enabling the translation of early-stage ideas into impactful solutions. The initiative reflects Bayer's commitment to fostering innovation through collaboration, with inaugural partners including Shanghai Industrial Investment Capital, Legend Capital, IDG Capital, and Bayland Capital. Additionally, Bayer Co.Lab Shanghai welcomed new biotech startups OTR Therapeutics and Nutshell Therapeutics, whose research aligns with Bayer's strategic priorities in addressing high unmet medical needs.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on September 08, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}